APP and Alzheimer disease: Notably, silencing Rab3 isoforms, except Rab3c, significantly reduces both Aβ and sAPP levels in non-neuronal cellular models expressing the pathogenic Swedish APP mutation, a mutation linked to familial early-onset AD.